• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多模态上转换纳米粒子的 PET 成像。

PET imaging with multimodal upconversion nanoparticles.

机构信息

Comprehensive Cancer Imaging Centre, Department of Surgery and Cancer, Hammersmith Campus, Imperial College London, Du Cane Road, London, W12 0NN, UK.

出版信息

Dalton Trans. 2014 Apr 14;43(14):5535-45. doi: 10.1039/c3dt53095g. Epub 2014 Feb 18.

DOI:10.1039/c3dt53095g
PMID:24535647
Abstract

A series of new upconversion nanoparticles have been functionalised with tumour-targeting molecules and metal chelates, prepared following standard peptidic and thiol chemistry. The targeting strategy has been delivered via the αvβ3 integrin, which is a heterodimeric cell surface receptor that is up-regulated in a variety of cancers, such as melanoma and breast cancer. The well-known DOTA (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid) motif allows coordination to the radionuclide (68)Ga. Radiolabelling experiments were optimised under relatively mild conditions, and are rare amongst nanoparticulate materials. In vivo application of these probes in mouse tumour models revealed their potential as specific cancer contrast agents for PET imaging.

摘要

一系列新的上转换纳米粒子已经通过肿瘤靶向分子和金属螯合物进行了功能化,这些靶向分子和金属螯合物是按照标准的肽和巯基化学方法制备的。该靶向策略是通过αvβ3 整合素来实现的,αvβ3 整合素是一种异二聚体细胞表面受体,在多种癌症中上调,如黑色素瘤和乳腺癌。众所周知的 DOTA(1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸)基序允许与放射性核素(68)Ga 配位。在相对温和的条件下优化了放射性标记实验,这在纳米颗粒材料中很少见。这些探针在小鼠肿瘤模型中的体内应用揭示了它们作为 PET 成像特定癌症对比剂的潜力。

相似文献

1
PET imaging with multimodal upconversion nanoparticles.多模态上转换纳米粒子的 PET 成像。
Dalton Trans. 2014 Apr 14;43(14):5535-45. doi: 10.1039/c3dt53095g. Epub 2014 Feb 18.
2
In vivo evaluation of a radiogallium-labeled bifunctional radiopharmaceutical, Ga-DOTA-MN2, for hypoxic tumor imaging.体内评估放射性镓标记的双功能放射性药物 Ga-DOTA-MN2 用于缺氧肿瘤成像。
Biol Pharm Bull. 2013;36(4):602-8. doi: 10.1248/bpb.b12-00982.
3
Ga-radiolabeled AGuIX nanoparticles as dual-modality imaging agents for PET/MRI-guided radiation therapy.镓标记的AGuIX纳米颗粒作为用于PET/MRI引导放射治疗的双模态成像剂。
Nanomedicine (Lond). 2017 Jul;12(13):1561-1574. doi: 10.2217/nnm-2017-0032. Epub 2017 Jun 16.
4
Preclinical evaluation of a dual sstr2 and integrin αβ-targeted heterodimer [Ga]-NOTA-3PEG-TATE-RGD.一种双 SSTR2 和整合素 αβ 靶向的杂二聚体 [Ga]-NOTA-3PEG-TATE-RGD 的临床前评价。
Bioorg Med Chem. 2019 Nov 1;27(21):115094. doi: 10.1016/j.bmc.2019.115094. Epub 2019 Sep 9.
5
Radiosynthesis, Biological Evaluation, and Preclinical Study of a Ga-Labeled Cyclic RGD Peptide as an Early Diagnostic Agent for Overexpressed Integrin Receptors in Non-Small-Cell Lung Cancer.镓标记环肽放射性药物的合成、生物学评价及初步临床研究——一种用于非小细胞肺癌过度表达整合素受体的早期诊断显像剂
Contrast Media Mol Imaging. 2020 Mar 31;2020:8421657. doi: 10.1155/2020/8421657. eCollection 2020.
6
Comparison of a Series of Ga-Labeled DOTA-LLP2A Conjugates for Positron Emission Tomography Imaging of Very Late Antigen-4 in Melanoma.用于黑色素瘤中极晚期抗原-4正电子发射断层显像的一系列镓标记的DOTA-LLP2A偶联物的比较
Mol Pharm. 2025 Feb 3;22(2):1031-1041. doi: 10.1021/acs.molpharmaceut.4c01204. Epub 2025 Jan 3.
7
PET/MRI dual-modality tumor imaging using arginine-glycine-aspartic (RGD)-conjugated radiolabeled iron oxide nanoparticles.使用精氨酸-甘氨酸-天冬氨酸(RGD)偶联的放射性标记氧化铁纳米颗粒进行PET/MRI双模态肿瘤成像。
J Nucl Med. 2008 Aug;49(8):1371-9. doi: 10.2967/jnumed.108.051243. Epub 2008 Jul 16.
8
Preparation and preclinical evaluation of (66)Ga-DOTA-E(c(RGDfK))2 as a potential theranostic radiopharmaceutical.(66)镓-多胺大环配体-乙二胺(环(RGDfK))₂作为一种潜在的治疗诊断放射性药物的制备及临床前评估
Nucl Med Biol. 2015 Feb;42(2):109-14. doi: 10.1016/j.nucmedbio.2014.09.010. Epub 2014 Oct 5.
9
Imaging of αβ integrin expression in experimental myocardial ischemia with [Ga]NODAGA-RGD positron emission tomography.利用[镓]NODAGA-RGD正电子发射断层扫描对实验性心肌缺血中αβ整合素表达进行成像。
J Transl Med. 2017 Jun 19;15(1):144. doi: 10.1186/s12967-017-1245-1.
10
(44)Sc: an attractive isotope for peptide-based PET imaging.(44)钪:一种用于基于肽的正电子发射断层显像(PET)成像的有吸引力的同位素。
Mol Pharm. 2014 Aug 4;11(8):2954-61. doi: 10.1021/mp500343j. Epub 2014 Jul 23.

引用本文的文献

1
Functional Diversity in Radiolabeled Nanoceramics and Related Biomaterials for the Multimodal Imaging of Tumors.用于肿瘤多模态成像的放射性标记纳米陶瓷及相关生物材料的功能多样性
ACS Bio Med Chem Au. 2023 Aug 8;3(5):389-417. doi: 10.1021/acsbiomedchemau.3c00021. eCollection 2023 Oct 18.
2
Nanoparticles labeled with gamma-emitting radioisotopes: an attractive approach for in vivo tracking using SPECT imaging.放射性核素标记的纳米颗粒:使用 SPECT 成像进行体内示踪的有吸引力的方法。
Drug Deliv Transl Res. 2023 Jun;13(6):1546-1583. doi: 10.1007/s13346-023-01291-1. Epub 2023 Feb 22.
3
Photon Upconversion in Small Molecules.
小分子上的光上转换。
Molecules. 2022 Sep 10;27(18):5874. doi: 10.3390/molecules27185874.
4
Ultra-sensitive Nanoprobe Modified with Tumor Cell Membrane for UCL/MRI/PET Multimodality Precise Imaging of Triple-Negative Breast Cancer.用肿瘤细胞膜修饰的超灵敏纳米探针用于三阴性乳腺癌的UCL/MRI/PET多模态精准成像
Nanomicro Lett. 2020 Feb 22;12(1):62. doi: 10.1007/s40820-020-0396-4.
5
Radiolabeled inorganic nanoparticles for positron emission tomography imaging of cancer: an overview.用于癌症正电子发射断层扫描成像的放射性标记无机纳米颗粒:综述
Q J Nucl Med Mol Imaging. 2017 Jun;61(2):181-204. doi: 10.23736/S1824-4785.17.02969-7. Epub 2017 Jan 26.
6
Positron emission tomography and nanotechnology: A dynamic duo for cancer theranostics.正电子发射断层扫描与纳米技术:癌症诊疗的活力组合。
Adv Drug Deliv Rev. 2017 Apr;113:157-176. doi: 10.1016/j.addr.2016.08.001. Epub 2016 Aug 9.
7
Nanogels as imaging agents for modalities spanning the electromagnetic spectrum.作为跨越电磁光谱各模态成像剂的纳米凝胶。
Mater Horiz. 2016 Jan 21;3(1):21-40. doi: 10.1039/c5mh00161g. Epub 2015 Oct 19.